Richard Payerchin

Company serves more than 100 million Americans.

De Beaumont Foundation has data from docs.

How did the pandemic effect the mission?

Working with patients as partners in health.

Doctors involved in medical investigations announced by HHS-OIG.

Primary care clinicians are busy, busy, busy.

Figures confirm ‘high burden’ and disparities in medical care based on race, ethnicity.

House Committee on Energy and Commerce to convene hearing this month.

AHRQ seeks clinics for research lasting up to five years.

Analyzing recommendations for preventive care.

Analyst tallies numbers Medicaid enrollment and treatment costs across the 50 states.

Evaluation process sparks public comments.

Commonwealth Fund survey shows differences among doctors in 10 developed nations.

Family physicians favor ban now under consideration by the Federal Trade Commission.

Public health emergency continues to May 11.

What does the USPSTF do? Its chairman explains.

Foundation offers possible solutions to poll findings as Public Health Emergency end approaches.

HHS’ cybersecurity agency warns about KillNet, other threats emerging and expected to continue this year.

Overall rate holding steady since early 2022, according to federal figures.

Primary care physicians are affected by the USPSTF.

U.S. Attorney’s Office announces sentence for medically unnecessary prescriptions.

An introduction to the new chair of the U.S. Preventive Services Task Force.

Physicians and other clinicians are dealing with burnout, moral injury, mental health stigma, and more. Health care leaders need their input to craft long-term solutions.

Drivers of health are a major factor creating stress for primary care physicians.

Even at 50% collection, doctors generate revenues worth more than their salaries.

Science and transparency are crucial for the panel that recommends what primary care physicians examine in patients.

Assume a 50% collection rate times the average amount collected per year, per specialty.

Legislation the latest step among lawmakers’ scrutiny of prescription drug costs.

COVID-19 exposed existing problems.

Report examines claims submitted by primary care doctors, specialists, and APPs. How do the numbers add up?